The IVI Pharmaceutical Corporation (DVM) has passed a Board resolution to borrow 70 billion VND from Shinhan Bank Vietnam. The funds are expected to be used to supplement the company’s production and business activities. The loan aims to ensure that DVM has sufficient financial resources to expand its production scale, enhance competitiveness, and meet market demands. Shinhan Bank Vietnam is considered a strategic partner for DVM at this stage, supporting the company in technological development and innovation in the pharmaceutical industry. This borrowing decision is a crucial step to strengthen DVM’s market position and create sustainable growth opportunities for the company in the future.
Leave a Reply